Robert Caccese

505 total citations
28 papers, 437 citations indexed

About

Robert Caccese is a scholar working on Rheumatology, Molecular Biology and Oncology. According to data from OpenAlex, Robert Caccese has authored 28 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Robert Caccese's work include Osteoarthritis Treatment and Mechanisms (8 papers), Receptor Mechanisms and Signaling (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Robert Caccese is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Receptor Mechanisms and Signaling (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Robert Caccese collaborates with scholars based in United States, Sweden and United Kingdom. Robert Caccese's co-authors include Richard P. Carlson, Suren N. Sehgal, John Zimmerman, G. DiPasquale, Linda A. Sygowski, Michael D.B. Swedberg, Thomas J. Hudzik, C.B. Caputo, Khanh Bui and Richard A. Roberts and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Robert Caccese

27 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Caccese United States 13 176 118 87 82 73 28 437
Monica Piccini Italy 8 240 1.4× 45 0.4× 31 0.4× 63 0.8× 35 0.5× 8 378
Yuji Saita Japan 11 161 0.9× 75 0.6× 46 0.5× 33 0.4× 115 1.6× 16 449
Tomiaki Asai Japan 11 135 0.8× 158 1.3× 83 1.0× 30 0.4× 104 1.4× 20 483
Yasuto Yamaguchi United States 10 195 1.1× 39 0.3× 49 0.6× 31 0.4× 35 0.5× 10 381
Richard L. Croxen United States 11 165 0.9× 64 0.5× 18 0.2× 84 1.0× 66 0.9× 13 421
Teruaki Mori Japan 13 183 1.0× 20 0.2× 45 0.5× 114 1.4× 109 1.5× 36 520
Qiaoqiao Wan United States 12 292 1.7× 40 0.3× 24 0.3× 68 0.8× 92 1.3× 15 471
Josef Novák United States 12 289 1.6× 37 0.3× 30 0.3× 119 1.5× 139 1.9× 25 567
Álvaro Valín Spain 14 473 2.7× 71 0.6× 50 0.6× 80 1.0× 218 3.0× 22 697

Countries citing papers authored by Robert Caccese

Since Specialization
Citations

This map shows the geographic impact of Robert Caccese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Caccese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Caccese more than expected).

Fields of papers citing papers by Robert Caccese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Caccese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Caccese. The network helps show where Robert Caccese may publish in the future.

Co-authorship network of co-authors of Robert Caccese

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Caccese. A scholar is included among the top collaborators of Robert Caccese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Caccese. Robert Caccese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grogan, Danielle, et al.. (2024). Harmonized Database of Western U.S. Water Rights (HarDWR) v.1. Scientific Data. 11(1). 598–598. 3 indexed citations
2.
Grogan, Danielle, et al.. (2020). HarDWR - Water Management Area (WMA) Shapefiles. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 4 indexed citations
3.
Hudzik, Thomas J., Robert Caccese, Khanh Bui, et al.. (2014). Effects of the δ opioid agonist AZD2327 upon operant behaviors and assessment of its potential for abuse. Pharmacology Biochemistry and Behavior. 124. 48–57. 17 indexed citations
4.
Woessner, Richard, Geraldine Bebernitz, Kirsten Bell, et al.. (2013). Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity.. Cancer Research. 73(8_Supplement). 931–931.
5.
Guha, Mausumee, Annabelle Heier, Sally Price, et al.. (2011). Assessment of Biomarkers of Drug-Induced Kidney Injury in Cynomolgus Monkeys Treated with a Triple Reuptake Inhibitor. Toxicological Sciences. 120(2). 269–283. 30 indexed citations
6.
Hudzik, Thomas J., Carla Maciag, Mark A. Smith, et al.. (2011). Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor. Journal of Pharmacology and Experimental Therapeutics. 338(1). 195–204. 44 indexed citations
7.
Rumsey, William L., David Aharony, Russell Bialecki, et al.. (2001). Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors. Journal of Pharmacology and Experimental Therapeutics. 298(1). 307–315. 25 indexed citations
8.
Bialecki, Russell, et al.. (1999). ZD1611, an Orally Active Endothelin-A Receptor Antagonist, Prevents Chronic Hypoxia-induced Pulmonary Hypertension in the Rat. Pulmonary Pharmacology & Therapeutics. 12(5). 303–312. 11 indexed citations
9.
Caccese, Robert, Alexander Graham, & Russell Bialecki. (1999). Pharmacological characterization of mucin secretion from CHO-K1-hNK1R cells. Neuropeptides. 33(3). 239–243. 1 indexed citations
10.
Caccese, Robert, et al.. (1993). Rapamycin's Inhibition of Thymocyte Proliferation, Unlike That of Cyclosporin A or Prednisolone, Is Not Associated with Cytotoxicity. Annals of the New York Academy of Sciences. 685(1). 114–116. 4 indexed citations
11.
Carlson, Richard P., et al.. (1993). Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune Diseases. Annals of the New York Academy of Sciences. 685(1). 86–113. 42 indexed citations
12.
Lewis, Gavin, et al.. (1993). Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells. Inflammation Research. 39(S1). C89–C92. 16 indexed citations
13.
Ocain, Timothy D., Daniel Angelo Longhi, Robert J. Steffan, Robert Caccese, & Suren N. Sehgal. (1993). A Nonimmunosuppressive Triene-Modified Rapamycin Analog Is a Potent Inhibitor of Peptidyl Prolyl cis-trans-Isomerase. Biochemical and Biophysical Research Communications. 192(3). 1340–1346. 23 indexed citations
14.
Caccese, Robert, John Zimmerman, & Richard P. Carlson. (1992). Bacterial lipopolysaccharide potentiates type II collagen‐induced arthritis in mice. Mediators of Inflammation. 1(4). 273–279. 38 indexed citations
15.
16.
Caccese, Robert, et al.. (1991). Inhibition of interleukin-1 (IL-1) induced neutral proteases from rabbit articular chondrocytes by WY-46,135 and WY-48,989. Inflammation Research. 34(1-2). 223–225. 14 indexed citations
17.
Koelle, George B., et al.. (1989). Glycyl-L-glutamine opposes the fall in choline acetyltransferase in the denervated superior cervical ganglion of the cat.. Proceedings of the National Academy of Sciences. 86(24). 10153–10155. 4 indexed citations
18.
Caputo, C.B., et al.. (1988). Degradation of rat chondrosarcoma proteoglycans by a neutral metalloprotease from rabbit chondrocytes. Connective Tissue Research. 18(3). 191–203. 3 indexed citations
19.
Caccese, Robert, et al.. (1987). Interleukin-1 induces chondrocyte protease production: The development of collagenase inhibitors. Inflammation Research. 21(3-4). 328–330. 3 indexed citations
20.
Caccese, Robert, et al.. (1986). Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. Clinical Immunology and Immunopathology. 41(3). 351–367. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Piccini Breakdown of academic impact, for papers by Yuji Saita Breakdown of academic impact, for papers by Tomiaki Asai Breakdown of academic impact, for papers by Yasuto Yamaguchi Breakdown of academic impact, for papers by Richard L. Croxen Breakdown of academic impact, for papers by Teruaki Mori Breakdown of academic impact, for papers by Qiaoqiao Wan Breakdown of academic impact, for papers by Josef Novák Breakdown of academic impact, for papers by Álvaro Valín
Rankless by CCL
2026